|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.62 USD | +3.49% |
|
+15.80% | -9.55% |
| 05-07 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
| 05-07 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Beam Therapeutics Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 98.67 million compared to USD 96.46 million a year ago. Basic loss per share from continuing operations was USD 1.21 compared to USD 1.33 a year ago.
Diluted loss per share from continuing operations was USD 1.21 compared to USD 1.33 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.55% | 1.94B | |
| +33.63% | 50.93B | |
| -0.09% | 42.12B | |
| +49.62% | 42.05B | |
| -4.96% | 29.18B | |
| +11.18% | 26.02B | |
| -21.95% | 18.9B | |
| +8.61% | 13.21B | |
| +24.73% | 12.17B | |
| +28.31% | 12.16B |
BEAM THERAPEUTICS INC. 
